-
Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
Thursday, November 21, 2024 - 4:49pm | 492Innocan Pharma Corporation (OTC:INNPF), an Israel-based cannabinoids-focused pharmaceutical company, reported a 174% year-over-year revenue growth, reaching $24 million for the first nine months of 2024. Quarterly revenues rose 111% YoY to $8.6 million, driven by robust sales from its subsidiary,...
-
France's Cannabis Plans Face Delays, Israel's Secret Weed Lab And More Global Updates
Tuesday, September 17, 2024 - 1:11pm | 896Irish Psychiatrists Demand Immediate Ban On This Synthetic Cannabinoid Over Safety Risks Ireland's public is worried about semi-synthetic cannabis and its availability across the European country. The College of Psychiatrists of Ireland urged the Government to swiftly ban the distribution and sale...
-
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
Saturday, September 14, 2024 - 2:32pm | 489InterCure Ltd. (NASDAQ:INCR) has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates. The company reported revenues of 126 million NIS ($33.97 million), surpassing the estimated 121 million NIS. ...
-
'The Whole World Is In Overdose,' Says CEO Of Company Behind Cannabis Inhaler That Enables Controlled Dosing
Monday, August 12, 2024 - 9:17am | 766"The medical establishment has largely concluded that cannabis is perhaps the best treatment for people with PTSD," Dr. Eytan Hyam, executive medical chairman of Syqe Medical and former director-general of Israel's Health Ministry, recently told The Jerusalem Post. However, there's the ongoing...
-
Promising Results In Medical Cannabis: CannaMore's Successful Phase 2a Trial For Colitis Treatment
Tuesday, July 23, 2024 - 3:42pm | 468Medical marijuana keeps showing positive results in treating various pathologies. CannaMore Biotechs, an Israel-based clinical-stage company, announced the successful completion of its Phase 2a clinical trial, which evaluated the safety and efficacy of a CBD-based enema formulation to treat...
-
Beyond Europe And North America: Curaleaf's Strategist On Cannabis Markets In Australia, New Zealand, And Israel
Monday, June 10, 2024 - 4:27pm | 991While much is known about the cannabis markets in Europe, the USA, and Canada, the real cash cows might lie in emerging regions. In an exclusive discussion with Benzinga Cannabis. Juan Martinez, head of Curaleaf International Holdings (OTC: CURLF), explored the strategic expansion into Australia,...
-
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
Tuesday, May 28, 2024 - 10:57am | 751InnoCan Pharma Corp. (OTCQB:INNPF) (CSE:INNO) (FSE: IP4) an Israel-based cannabinoids-focused pharmaceutical company, announced its interim consolidated financial results Monday for the three months ended March 31, 2024. The company reported revenues of $6.8 million, marking a 334% increase...
-
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
Friday, May 24, 2024 - 4:13pm | 949The potential rescheduling of cannabis in the U.S. and the growing demand in Germany positions InterCure (NASDAQ: INCR), the leading seller of pharmaceutical cannabis outside North America, to capitalize on these opportunities, according to a recent initiation note by Pablo Zuanic of Zuanic...
-
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
Tuesday, April 2, 2024 - 4:28pm | 768Innocan Pharma Corporation (OTCQB:INNPF) (CSE:INNO) (FSE: IP4), a cannabinoids-focused pharmaceutical company based in Israel, announced Monday its financial results for the the year ended December 31, 2023. The company reported a nearly sixfold increase in its revenues, reaching US$13.7 million,...
-
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
Thursday, March 28, 2024 - 11:19am | 873IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial and operational results on Thursday for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36...
-
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Thursday, March 7, 2024 - 10:20am | 722Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced on Thursday its financial results for the fourth quarter and full-year period ending December 31, 2023. In the fourth quarter revenues amounted to $578 000, down 12% year-over-year. However, the Rehovot, Israel-based cannabis company reported $5.6...
-
Top Canadian Cannabis Producers Caught In International Controversy Over Imports
Thursday, February 1, 2024 - 3:00pm | 971A group of Canadian cannabis producers found themselves in hot water after the commissioner of Israel’s Trade Levies Unit launched an "anti-dumping" investigation related to the import of medical cannabis from Canada, as reported by Marijuana Business Daily's Matt Lamers. Danny Tal, director...
-
War In Gaza Forces Israel To Delay Medical Cannabis Reform
Friday, December 8, 2023 - 2:47pm | 737The Israel Ministry of Health announced the anticipated reform of medical cannabis regulations in the country in August, which was expected to come into effect on Dec. 29, 2023. However, due to the Israel-Hamas war, the anticipated implementation of the medical cannabis regulatory reform has been...
-
Tilray CEO Irwin Simon Visits Israel To Meet Business Partners And Germany Ahead Of Imminent Legalization
Tuesday, December 5, 2023 - 11:43am | 852Irwin Simon, a chairman and CEO of the largest Canadian cannabis company in the world, Tilray Brands (NASDAQ: TLRY), recently took a business and personal trip to Israel amid the war with Hamas and to Germany, as legal cannabis seems to be on the horizon. In an exclusive interview with...
-
Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon
Wednesday, November 22, 2023 - 11:17am | 816Over the years, Israel has grown into an international giant in the cannabis industry. Recent regulatory reforms approved by the Israeli Ministry of Health allowed physicians to prescribe cannabis to patients as a first-line treatment. Israel has seen a significant increase in the number of...